1. Home
  2. OPK vs MDXG Comparison

OPK vs MDXG Comparison

Compare OPK & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • MDXG
  • Stock Information
  • Founded
  • OPK 2007
  • MDXG 2006
  • Country
  • OPK United States
  • MDXG United States
  • Employees
  • OPK N/A
  • MDXG N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • OPK Health Care
  • MDXG Health Care
  • Exchange
  • OPK Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • OPK N/A
  • MDXG 877.4M
  • IPO Year
  • OPK 1995
  • MDXG N/A
  • Fundamental
  • Price
  • OPK $1.34
  • MDXG $6.80
  • Analyst Decision
  • OPK Buy
  • MDXG Strong Buy
  • Analyst Count
  • OPK 4
  • MDXG 2
  • Target Price
  • OPK $2.75
  • MDXG $12.50
  • AVG Volume (30 Days)
  • OPK 3.3M
  • MDXG 755.3K
  • Earning Date
  • OPK 08-06-2025
  • MDXG 07-30-2025
  • Dividend Yield
  • OPK N/A
  • MDXG N/A
  • EPS Growth
  • OPK N/A
  • MDXG N/A
  • EPS
  • OPK N/A
  • MDXG 0.27
  • Revenue
  • OPK $689,408,000.00
  • MDXG $352,375,000.00
  • Revenue This Year
  • OPK N/A
  • MDXG $9.55
  • Revenue Next Year
  • OPK $6.98
  • MDXG $11.43
  • P/E Ratio
  • OPK N/A
  • MDXG $24.67
  • Revenue Growth
  • OPK N/A
  • MDXG 5.34
  • 52 Week Low
  • OPK $1.21
  • MDXG $5.47
  • 52 Week High
  • OPK $2.04
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • OPK 50.30
  • MDXG 60.83
  • Support Level
  • OPK $1.33
  • MDXG $6.57
  • Resistance Level
  • OPK $1.36
  • MDXG $7.05
  • Average True Range (ATR)
  • OPK 0.04
  • MDXG 0.24
  • MACD
  • OPK 0.01
  • MDXG 0.11
  • Stochastic Oscillator
  • OPK 61.54
  • MDXG 78.99

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: